J&J Topamax Approved For Migraine Prevention In Twice-Daily Dose
This article was originally published in The Pink Sheet Daily
Executive Summary
The supplemental indication for topiramate clears FDA. The recommended twice-daily dose for migraine prevention may place Topamax at a disadvantage to Abbott’s once-daily dosing for Depakote ER.